Snake venom serine proteases (SVSPs) Crotalus simus Hesperetin Enzymes inhibition in silico and in vitro analyses a b s t r a c t Around 5.5 million people suffer from snakebites per year, with about 400,000 cases with some type of sequelae, such as amputation, and 20,000 to 125,000 cases with the fatal end. Usually, the victim outcome depends on correct, agile and many times in situ intervention based on the proper identification of the snake venom type and its potential effects, among other factors. Therefore, knowledge on the snake venom composition and a research on inhibitors of snake venom target components might ameliorate envenoming dangerous outcome. Herein, two thrombin-like serine proteases from the Crotalus simus snake venom -SVSP1 and SVSP2 -were isolated in two chromatographic steps, using gel filtration and then RP-HPLC. They showed molecular masses of around 31.3 and 24.6 kDa, respectively, and mostly b-sheet secondary structure features. The SVSP1 and SVSP2 were sequenced using tandem mass spectrometry (Q-TOF). Using the known serine protease structure (PDB entry: 4e7n), which was evaluated as homologous to the two target proteins, in silico docking results showed that hesperetin is its excellent inhibitor. Using in vitro tests with the commercial hesperetin, kinetic parameters were obtained for SVSPs against the synthetic substrate BApNA. Obtained results pointed that hesperetin might act as an uncompetitive (SVSP1) or mixed (SVSP2) inhibitor. Also, the fluorescence quenching upon inhibition was observed, as well as, red shift in maximums of around 20 nm, which indicate that the tryptophan residues in the target enzymes suffered conformational changes caused by hesperetin binding. Thus, a naturally occurring flavone that can easily be extracted from oranges might serve as low-cost inhibitor of the investigated snake venom proteases.
Introduction
Snakebite envenoming is a global and neglected public health problem. Up to 5 million snakebites have been reported per year in the World, and around 125,000 deaths and close to three times this number of people that suffer from some permanent sequel (Chippaux, 1998; World Health Organization, 2007) . Among many snake venom components, the proteases are encountered as an abundant part of proteins present and may cause various physiological effects after delivered into a human tissue. The disturbances on hemostasis were shown to be directly involved in proteolytic events caused by the serine protease effects (Serrano and Maroun, 2005; Kini, 2005) . These enzymes also affect blood coagulation, platelet aggregation and fibrinolysis, among others. And, bloodclotting disturbance is one of the most dramatic effects of viperid and crotalid snake envenomation.
Snake venom serine proteases (SVSPs) catalyze the cleavage of peptide bonds in proteins and play key role in diverse biological processes ranging from digestion to the control and regulation of blood coagulation, the immune system and inflammation (Kang et al., 2011) . They interfere in regulation of key biological reactions in the blood coagulation cascade, fibrinolytic system and blood platelet activation. In addition, SVSPs display high specificity toward distinct substrates and have been classified depending on their specific role as activators of the fibrinolytic system, procoagulants, anticoagulants and platelet-aggregating enzymes.
Nature is an attractive source for novel drug candidates due to the huge chemical diversity found in millions of species. In spite of advances and technological progress in combinatorial and synthetic chemistry, drugs derived from natural products still make an enormous contribution to drug discovery (da Rocha et al., 2001) . For example, flavonoids are the main class of polyphenols present in plants (Manach et al., 2004; Manthey and Grohmann, 1996) . They are ketone-containing compounds that have different functions. For instance, hesperidin -glycosylated flavonoid is the most abundant in different citrus fruits -with 40 mg of this compound per 100 g of orange fruit. Different studies showed that hesperidin has very interesting biological properties as antioxidant (Wilmsen et al., 2005; Tasic et al., 2016) and also anti-inflammatory (Emim et al., 1994) agent. Some have been using it as serine protease inhibitors as in Dengue virus (de Sousa et al., 2015) and for human thrombosis relief (Mozzicafreddo et al., 2006) . Recently, it was described in literature that hesperetin can act as an inhibitor of Chikungunya virus replication (Ahmadi et al., 2016.) . But, its inhibitory effects on serine proteases from snake venoms have not been reported up to the moment.
Herein we present pioneer results on hesperetin inhibitory activity against two serine proteases purified from the venom of the Crotalus simus, also known as Central American rattlesnake. Hesperetin showed strong interactions with both enzymes and acted as mixed or uncompetitive inhibitor, depending on serine protease studied.
Materials and methods

Materials
Liofilizated Crotalus simus venom was purchased from the Instituto Clodomiro Picado (San Jos e, Costa Rica).
All chemicals and reagents used in this work were analytical, HPLC or sequencing grade. Chromogenic synthetic substrate N abenzoyl-DL-arginine-4-nitroanilide hydrochloride (BApNa) and hesperetin were obtained from Sigma Chemical Co (St. Louis, MO, USA).
Purification of serine proteases
Crotalus simus whole venom (500 mg) was dissolved in 1 mL of 0.2 mol dm À3 ammonium bicarbonate buffer (pH 8.0), followed by a clarification step using high-speed centrifugation (10,000 g for 5 min) in an Eppendorf Centrifuge MiniSpin ® plus. The supernatant was recovered and applied on a molecular exclusion chromatography column system Sephadex G-200 and Sephadex G-75 connected in series (2.5 cm Â 50 cm) previously equilibrated with the buffer used for venom dissolution. The fractions were separated at a constant flow rate of 1 mL min
À1
. The elution profile was monitored at 280 nm. Fractions of 3 mL were collected, lyophilized and stored at À20 C.
Only fraction 4 that presented proteolytic activity was assayed in the second chromatographic step using a semi-preparative reverse phase HPLC column (Discovery ® BIO C5, 10 mm, 10 mm Â 250 mm) (RP-HPLC). The sample (fraction P4) was dissolved in 300 mL of aqueous solution of trifluoroacetic acid 0.1% (TFA; buffer A) until complete dissolution, followed by clarification using high-speed centrifugation (10,000 g for 5 min) in an Eppendorf Centrifuge MiniSpin ® plus. The supernatant was then loaded onto column and elution was carried out using a linear gradient of buffer B (acetonitrile 60%, ACN, containing 0.1% TFA) at constant flow rate of 2 mL min À1 using a Waters 515 chromatograph. 
SDS-PAGE
Electrophoresis was carried out in polyacrylamide gels (SDS-PAGE) at 12% under reduced conditions (Laemmli, 1970) . This procedure was used to estimate the molecular masses of the proteins. Before electrophoresis, 10 mL of the samples were boiled for 5 min in 10 mL sample reducing buffer which contained glycerol 10% (v/v), SDS 4%, 2-mercaptoethanol 5%, and bromophenol blue 0.05% (w/v). Protein molecular masses marker (Full-range Rainbow Marker, GE, USA) was included in each run.
Circular dichroism (CD)
CD spectra were obtained from SVSPs solutions prepared at similar concentrations (around 0.3 mg cm À3 : 1 at concentration of 0.27 mg cm À3 and 2 at 0.23 mg cm À3 ), with 10 mmol dm À3 Tris-HCl and at pH 8.0. The spectra were recorded from 200 to 260 nm with a Jasco J-720 spectropolarimeter (JASCO International Co. Ltd., Tokyo, Japan). Spectra were acquired at 25 C using 1 mm path length cell, spectra were expressed as an average over 8 scans at a scan speed of 20 nm min
À1
.
Mass spectrometry analysis (LC-MS/MS)
For MS/MS analysis, 10 mL of enzymes were digested using dithiothreitol solution (10 mmol dm À3 in 1 mL of ammonium bicarbonate 100 mmol dm
À3
) and incubated during 30 min at 60 C. Thereafter, solution of iodoacetamide (50 mmol dm À3 in 1 mL of ammonium bicarbonate 100 mmol dm À3 ) was added and the mixture was incubated during 30 min at room temperature protected from the light. Then, 1 mL of trypsin (EC 3.4.21.4 Type XIII:
From Bovine Pancreas; 11.700 units/mg solid, Sigma Aldrich) in concentration 20 ng mL À1 was added and incubated for 16 h at 37 C.
Formic acid at the final concentration of 1% was utilized to interrupt the reactions. Peptides obtained from trypsin-lyses of proteins were concentrated through the solid-phase extraction process using Waters OASIS HLB Cartridge 30 mm (30 mg). After loading, the cartridge was washed with 1 mL of 30% ACN and 0.1% formic acid, and purified peptides were lyophilized. These samples were analyzed by LC-MS/MS. Samples of trypsin-lysed proteins were dissolved in acetonitrile and their aliquots of 4.5 mL were separated by C18 (75 mm ✕ 100 mm; 1.7 mm; 13 nm) RP-nanoUPLC (nanoAcquity, Waters) at a flow rate of 0.6 mL min
À1
, and analyzed with a Q-TOF Premier mass spectrometer (Waters) using a nano-electrospray source. The gradient was 2e90% acetonitrile with 0.1% formic acid over 45 min. The nano-electrospray voltage was set to 3.5 kV, a cone voltage of 30 V and the source temperature was 100 C. The instrument was operated in the 'top three' mode, in which MS/MS of the three most intense peaks were recorded. The tryptic-peptide samples were analyzed in triplicates.
MS/MS data analysis
The spectra were acquired using software MassLynx v.4.1 and the raw data files were converted to a peak list format ( 
Fibrinogenolytic activity
A blood sample, from a donor that signed the consent form for taking part in this research, was collected in a 4.5 mL BD Vacutainer tube containing sodium citrate buffer 0.105 mol dm À3 (which corresponds to approximately 3.2% of the final volume). Then, blood sample was centrifuged at 5000 rpm for 10 min, what caused plasma separation from the pellet -formed from two layers (erythrocytes and leukocytes). To a volume of 200 mL of plasma, 10 mL of SVSP1 were added, and to the same plasma volume in the second tube, 10 mL of SVSP2 were added; and tubes were incubated for 4 h at 37 C.
In vitro protease assays
The enzymatic activity of the venom fractions and the purified and isolated serine proteases were measured using the synthetic substrate BApNA (Erlanger et al., 1961) proteins (SVSP1 and SVSP2) showed to be thrombin-like serine proteases, and similar to protease from the venom of Agkistrodon halys (PDB entry: 4e7n). Thus, this protein 3D structure has been chosen for in silico analysis. The target structure was prepared for computational molecular docking experiments using the Protein Preparation protocol from Discovery Studio (BioVia Software Inc., v4.0.0.13259) with the following steps: deleting alternate conformations (disorder), removing water molecules and ligands, and finally protonating titratable residues using predicted pK values at pH 7.4.
2.9.1.2. Compound preparation. Compounds selected for the molecular docking were downloaded from the PubChem (http://www. ncbi.nlm.nih.gov/pccompound) and then prepared using the protocol "Prepared Ligand" as implemented in Discovery Studio. This protocol creates viable 3D conformations considering different ionization states, isomers and tautomers. Ionization states were enumerated over the pH range of 6.5e8.5.
2.9.1.3. Molecular docking protocol. Molecular docking studies were performed using the protocol "CDOCKER with QM Charges" as implemented in PipelinePilot (BioVia Software Inc.) with default parameters. This protocol comprises three main steps. First step consists of the initial placement of the ligand in the binding site using CDOCKER (Wu et al., 2003) , a CHARMm-based molecular dynamics (MD) docking program, followed by a RMSD filter procedure to ensure that initial ligand poses (predicted binding modes) are diverse. In step two, ligand atomic charges are calculated for each pose by quantum mechanical methods (QM) in the presence of the enzyme. More specifically, QM charges calculation is performed using dmol3 with the PBE functional. Lastly, in the third step the ligand is re-docked with CDOCKER considering atomic ligand charges calculated previously.
Effects of the inhibitor e hesperetin: in vitro analysis
The activities of target enzymes were examined in the presence of hesperetin. Procedure for the enzymes' activity determination was the same as described previously in the section -In vitro protease assays, with the additions of 1 mL of hesperetin, concentration 1.0 mg cm À3 in dimethyl sulfoxide (DMSO). And K' M , V' max and k' cat in the presence of inhibitor were determined.
Fluorescence experiments
The fluorescence spectra of: (A) SVSP1 pure and with hesperetin and (B) SVSP2 pure and with hesperetin (SVSP1 in concentration of 0.09 mg cm À3 and SVSP2 in concentration of 0.15 mg cm
À3
) were monitored with a Varian (Varian, Palo Alto, USA) spectrofluorimeter using a 1 mm path length quartz cuvettes and total volume of 300 mL. All protein solutions were prepared with 10 mmol dm
Tris-HCl buffer (pH 8.0). Titration with DMSO solution of hesperitin (1 mg cm À3 ) were performed, and correspondent DMSO volumes were added to each protein solution and used as blank as to avoid solvent effect on proteins' folding. Fluorescence spectra were measured between 300 and 500 nm after excitation at 280 nm or 295 nm.
Results and discussion
Snakebites envenomation requires emergency medical care. Nowadays, serotherapy is the most effective treatment for human envenomation. However, this approach still presents some weakness, such as: limited access to antivenoms in the rural areas of (Tasoulis and Isbister, 2017) and antigenic reactivity due to snake diversity; and limited effectiveness to protect against the rapid local tissue damaging effects. Hence, the identification of novel compounds that might be useful as effective and inexpensive complementary therapies to improve the treatment of snakebite envenomation, renders the inhibitors development even more attractive (Panfoli et al., 2010) . Natural inhibitors of snake venom toxins had shown a meaningful role in neutralization of harmful effects induced by venoms. Some plant extracts are able to neutralize snake venom toxins as well. Several plants have been utilized in folk medicine as antiophidians (Martz, 1992; Panfoli et al., 2010) . Previous research had shown that agroindustrial residues, such as from Citrus sinensis, seeds of Vitis vinifera and almonds of Mangifera indica, have the capacity to neutralize some of the enzymatic effects induced by Porthidium nasutum and Bothrops asper venoms (Pereañez et al., 2009) . Flavonoids, hesperidin and hesperetin, are compounds with a wide range of bioactivities. Some previous reports had shown their inhibitory activities on some serine proteases, for example, thrombin, urokinase, plasmin and trypsin (Cuccioloni et al., 2009; Jedin ak et al., 2006) , but, not the ones from the snake venoms. Since SVSPs play a relevant role in the hemostatic disturbances in snakebites (Markland, 1998; Matsui et al., 2000) , their inhibition becomes important research task as to minimize their maleficent effects.
Computational molecular docking studies were performed to assess the possibility of serine protease thrombin-like being inhibited by flavonoids. Considering seven possible binding sites ( Fig. 1A and Fig S2, Supplementary Material) on the target structure (4e7n.pdb), two flavonoids (hesperidin and hesperetin) and three known serine proteases inhibitors (Nafamostat, Sivelestat sodium salt and Camostat mesylate) were docked using the protocol as described in Materials and methods section. Fig. 2 depicts the chemical structures of those five compounds. Predicted binding modes were evaluated in terms of CDOCKER energy, and binding energy estimation calculated based on the internal ligand strain energy and the protein-ligand interaction energy.
Although performing molecular docking in seven different sites on the target structure, only sites #1 and #3 showed interesting results in terms of SVSP-flavonoid binding (Table 1 and S1, Fig. S3 ). Specifically, for the binding Site #1, which is close to catalytic residues His57 and Ser195, molecular docking results suggest that hesperetin could form a hydrogen bond with Arg60 and His57 with the hydroxyl group on the carbon-5 from its A ring. The oxygen atom 1 in the ring C could form hydrogen bonds with the Gly193 and Lys192. In addition, the methoxy group of the B ring could form hydrogen bond with the Gly216 and Asp217. These results may suggest that hesperetin blocks the interaction between the enzyme catalytic residues and the substrate (Fig. 1B and C) .
It is also important to note that the enzyme's site #3, which showed to be an interesting site for the hesperetin binding, somewhat distant to the catalytic triad, might be used to explain un-competitive kinetics observed in studies to be discussed next.
Two enzymes from the class of SVSP from Crotalus simus venom were isolated using the combination of molecular exclusion system (serial connection of Sephadex 75 and 200). The first step was prepurification of serine proteases from the total venom. Fractions belonging to the 1, 2, 3 and 4 peaks showed the serine protease activity in BApNA tests. Then, the fraction denoted as peak 4 (Fig. 3A) was additionally purified with a semi-preparative reversephase C5 column (Fig. 3B ) and the target proteins were isolated and tested additionally with BApNA (Fig. S4, Supplementary Material) . These one-chain proteins with molecular masses of 31.3 and 24.6 kDa (Fig. 3B) were named SVSP1 and SVSP2, respectively. Thus, the molecular masses found for our-target SVSPs were similar to already reported data. It is important to state that for the SDS-PAGE (presence of SDS and DTT) samples were heated 5 min at 95 C, and in the lane where detected SVSP2 (24.6 kDa), another band at z 15 kDa was observed, which is very probably product of this serine protease autolysis.
The majority of thrombin-like enzymes show one chain and molecular masses from 26 to 67 kDa as consequence of glycolysation (Serrano and Maroun, 2005) , which provokes heterogeneity among them (Calvete, 2010) . N-glycosylation interferes on catalytic activity of these enzymes and Komori and Nikai (1998) Fig. 5 . Tandem-MS/MS spectrum of the peptide from the trypsin lysed SVSP2 protein -series of y fragment ions were used to determine the sequence of the peptide amino acid sequence given in one letter code.
described that carbohydrates may stabilize and enhance SP catalytic activity.
As to verify these proteins' activity, we used the clothing blood plasma test. Blood is composed from the red cells (erythrocytes), white cells (leukocytes), platelets (thrombocytes), and plasma (Fig. S5A, Supplementary Material) . Blood plasma, which corresponds to 50e55% of the blood, contains fibrinogen, thrombocytes and other factors responsible for blood coagulation (Fox, 1999; West, 1985) . With the use of an anticoagulant agent -sodium citrate, blood clothing was prevented. But, when small amounts of the target proteins, SVSP1 or SVSP2, were added (Fig. S5B , Supplementary Material), the blood plasma coagulation occurred as noticed by turbidity of plasma that turned gelatinous.
As assessed through the circular dichroism (CD) data (Fig. 4 and Table 2 ), the SVSP1 presented around 58% of b-sheets, followed by random-coil (35%) and a-helix (8%) elements. The SVSP2 presented somewhat lower content of b-sheets (43%), followed by almost identical random-coil (35%) and almost triple as high a-helix (22%) elements. Therefore, target serine proteases showed to be slightly different as if a part of b-sheets in SVSP1 was involved in a-helix (of around 15%) elements in SVSP2. Some differences in secondary structure features among proteins from the same family are not rare. Both target proteins showed to be rich in the b-sheets elements, as well as the protein used as their 3D model (Fig. 1A ) in previously presented in silico research. Three independent trypsin-lysed samples from SVSP1 and SVSP2 were analyzed by MS/MS. Data obtained are summarized in Table 3 . Also, MS/MS data for one peptide fragment of SVSP2 are illustrated in Fig. 5 .
Alignments of the fragments with the highest scores obtained by MS/MS are presented in Fig. S1 (Supplementary Material) . A great similarity with other thrombin-like enzymes from other Crotalus, such as B0FXM2, J3RYA3 and F8S114 (UniProt annotations) and with one form Lachesis species -P33589 (UniProt), was noticed. Also, sequence similarities among SVSP1 and SVSP2 and the glycosylated snake venom thrombin-like enzyme from Agkistrodon halys (4e7n.pdb) were observed e and this protein was explored as SVSP model structure for in silico assays. According to Durban and col. (Durban et al., 2013) , the found SVSP1 sequence is also similar to the clone 3 obtained trough the SerProt miRNA sequences from the Crotalus simus simus.
Enzymes' kinetic parameters V max and K M were obtained using BApNA as a substrate and the Michaelis-Menten (Fig. 6A) and Lineweaver-Burk equations (Fig. 6B) . The parameter values are shown in Table 4 , showing that the hesperetin reduced the affinity of the investigated target serine proteases over the BApNA substrate. Obtained results (Fig. 6 and Table 4) point that hesperetin probably works as an uncompetitive inhibitor for SVSP1 and a mixed inhibitor for SVSP2. Uncompetitive inhibitor is the one that binds into an allosteric enzyme site, and presents values for both V max and K M lower then when inhibitor was absent. On the other hand, mixed inhibitor also would bind into the site that is different from the catalytic enzyme site where substrate binds and is seen as a mixture of competitive and uncompetitive inhibition, altering both measured values (V max and K M ), as well (Nelson and Cox, 2006) .
As shown in Fig. 7 , our targets SVSP1 and SVSP2 suffered alterations in their fluorescence spectra upon interacting with the hesperetin. Quenching of the fluorescence for both SVSPs solutions seized when 10 mL of hesperetin solution reached the concentration of 1.0 mg cm À3 . Also, red-shifts in maximums of fluorescence were observed for SVSP1 of around 20 nm and for the SVSP2 of 17 nm, indicating 3D structure modifications that proteins underwent after binding with the hesperetin.
In conclusion, two serine proteases, named SVSP1 and SVSP2 were successfully isolated from the Crotalus simus (Costa Rica) venom and biochemically characterized. Citrus flavonone e hesperetin binds to both of them and inhibits their proteolytic activities in very significant manners. Quenching and displacement of maximums in fluorescence point to changes in these SVSP conformations upon binding with the hesperedin. Thus, performed in vitro assays and in silico results might point to a new structure e flavonone as interesting for inhibition for snake venome serine proteases, and open up a possibility for drug design of snake venome serine protease inhibitors. ). Red-shifts in fluorescence maximums and quenching of fluorescence observed in both cases are indicative for SVSPs and hesperetin binding.
